ONUREG
RegisteredCombined Mark
•
Ownership
CC
Owner Name
Type: Organization / Corporation
Address
86 Morris Avenue
Summit, NJ 07901
Critical Dates
First Use Date
Sep 1, 2020
Filing Date
Aug 27, 2020
Registration Date
Jan 4, 2022
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for human use, namely, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use for the treatment of blood disease and cancer
Mark Elements
Text Mark
ONUREG
Category
Trademark
Standard Characters
No
Color Claim
No
Drawing/Image Description
The mark consists of a design of circles and curved lines positioned to the left of the word "ONUREG" in stylized font.
Design Search Codes
26.01.02
Circles with plain outline not used as carriers or borders26.17.09
Bands, curvedRelated Registrations
4559839
ONUREG
DEAD - CANCELLED
TrademarkWordOwner: Celgene Corporation
Status: CANCELLED – SECTION 8
Record Details
Serial No.
86115220
Registration No.
4559839
Relation
Related registration
Important Dates
Filed
Nov 11, 2013
Registered
Jul 1, 2014
5965654
ONUREG
LIVE - REGISTERED
TrademarkWordOwner: Celgene Corporation
Status: SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Record Details
Serial No.
88490065
Registration No.
5965654
Relation
Related registration
Important Dates
Filed
Jun 26, 2019
Registered
Jan 21, 2020
Goods & Services
Class 005
Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of blood disease and cancer
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
No documents found for this trademark.
AI Assessment
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach